SCHEMBL21716762

SCHEMBL21716762

c1ccc(-c2ccc(-c3nc4ccccc4nc3-c3ccc4ccc(-n5c6ccc(-n7c8ccccc8c8ccc9ccccc9c87)cc6c6cc7ccccc7cc65)cc4c3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
HPGD P15428 1/20 0.33
MAPK8 P45983 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK10 P53779 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
PRSS1 P07477 1/20 0.32
NPY5R Q15761 1/20 0.32
L3MBTL1 Q9Y468 3/20 0.32
LMNA P02545 3/20 0.32
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
THRB P10828 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HTR2B P41595 1/20 0.31
HTR5A P47898 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716504 0.97 L3MBTL1 (0.33) ADORA2AADORA1HPGDMAPK8MAPK9
SCHEMBL21716498 0.95 HPGD (0.33) HPGDMAPK8MAPK9MAPK10F2
SCHEMBL21717217 0.94 HPGD (0.31) HPGDNPY5RPDPK1RAC2RAC3
SCHEMBL21716752 0.94 L3MBTL1 (0.34) HPGDF2F10PRSS1NPY5R
SCHEMBL21717654 0.94 MAPK8 (0.34) ADORA2AADORA1HPGDMAPK8MAPK9
SCHEMBL21716746 0.93 L3MBTL1 (0.35) HPGDF2F10PRSS1NPY5R
SCHEMBL21717050 0.93 ADORA2A (0.38) ADORA2AADORA1HPGDMAPK8MAPK9
SCHEMBL21716450 0.93 ADORA2A (0.38) ADORA2AADORA1HPGDMAPK8MAPK9
SCHEMBL21717226 0.92 KDM4E (0.35) HPGDF2F10PRSS1NPY5R
SCHEMBL21716491 0.91 L3MBTL1 (0.36) HPGDMAPK9MAPK10F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2021-12-07 US disclosed
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192884-B2 Heterocyclic compound and organic light-emitting device comprising same CYP1A1, CYP1B1, CRY1 ADORA2A 3144/4885ADORA1 1546/4885HPGD 652/4885
US-20200048226-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CYP1A1, CYP1B1, CRY1 ADORA2A 3144/4885ADORA1 1546/4885HPGD 652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.